Decision-making using fMRI in clinical drug development: revisiting the NK-1 receptor antagonist for pain. Posted By: NITRC ADMIN - May 15, 2012Tool/Resource: Journals Decision-making using fMRI in clinical drug development: revisiting the NK-1 receptor antagonist for pain. Drug Discov Today. 2012 May 10; Authors: Borsook D, Upadhyay J, Klimas M, Schwarz AJ, Coimbra A, Baumgartner R, George E, Potter W, Large T, Bleakman D, Evelhoch J, Iyengar S, Becerra L, Hargreaves R PMID: 22579743 [PubMed - as supplied by publisher] Link to Original Article |
Latest News |
|